TBC1D1 and lymphopenia: We do not know whether the lymphopenia truly reactivated the Tbc in this case; nevertheless, these findings imply that in areas like Korea with a high prevalence of Tbc, a Tbc screening test such as the interferon‐gamma release assay (IGRA) should be performed to determine whether a patient has latent Tbc before ICI treatment is started.